Table 1.
Characteristics of the study cohort (N=2857) at baseline and at first proteinuria (P/Cr) measurement.
| Characteristic | Baseline | First P/Cr measurement |
|---|---|---|
| Age (years), median (IQR) | 39 (33, 46) | 42 (36, 49) |
| Female sex, n (%) | 482 (17) | 482 (17) |
| Non-Hispanic Black, n (%) | 805 (28) | 805 (28) |
| CD4 count (cells/µL) | ||
| Median (IQR) | 234 (98, 384) | 438 (282, 636) |
| Less than 200, n (%) | 1621 (57) | 877 (31) |
| HIV-1 RNA | ||
| Median (IQR),log10copies/mL | 4.6 (4.0, 5.3) | <1.7 (<1.7, 2.3) |
| Less than 400 copies/mL, n (%) | 194 (7) | 1770 (78) |
| GFR, mL/min/1.73m2 | ||
| Median (IQR) | 99 (86, 116) | 99 (85, 115) |
| Less than 60, n (%) | 77 (3) | 76 (3) |
| History of diabetes mellitus, n (%) | 226 (8) | 226 (8) |
| History of hypertension, n (%) | 587 (21) | 587 (21) |
| Hepatitis B, n (%) | 137 (5) | 139 (5) |
| Hepatitis C, n (%) | 326 (11) | 326 (11) |
| Antiretroviral-naïve at baseline, n (%) | 1908 (67) | 1908 (67) |
Baseline defined as time at entry to parent protocol
IQR, interquartile range
GFR, glomerular filtration rate estimated using the simplified MDRD equation